Alternatives to Element Biosciences

Developing breath-based diagnostics for lung diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Develops and distributes bioreactor technology for stem cell cultivation.

AI-enabled technology for cell biology research and biopharma development.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing an automated platform for liquid biopsy sample preparation.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A global leader in clinical pharmacology and bioanalytical sciences.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

AI-powered precision testing for patient identification in clinics and clinical trials.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered knowledge discovery for life sciences.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Developing ultrasound-mediated nonviral genetic medicines.

Developing AI-powered diagnostics for neurodegenerative diseases.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Developing oral small molecule medicines for immunological and chronic diseases.

Developing advanced vision restoration technology through a retinal implant.

Developing novel therapies to reverse aging and extend lifespan.

Advancing next-generation mRNA medicines.

Establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases.

Digital pathology imaging technology and AI-driven precision pathology software.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing lightweight bionic technology.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Wilbe provides flexible lab infrastructure and services for science startups.

Developing a novel therapeutic approach for Alzheimer's disease.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Developing soft, stretchable brain-computer interface platforms.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Scalable, one-time curative in-vivo gene editing therapies.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Developing novel male contraceptives.

Unleashing the power of genomics at scale for biological advances and human health.